Datum | Källa | Rubrik | Typ | Alternativ |
---|---|---|---|---|
2023-07-13 | Integrum | Integrum AB: Integrum's technology using AI gives an above-elbow amputee unprecedented control of every finger in a bionic hand | Pressreleaser | Visa Stäng |
|
||||
2023-06-22 | Integrum | Integrum AB: Integrum har informerats om att Nämnden för prövning av oredlighet i forskning har friat Rickard Brånemark | Pressreleaser | Visa Stäng |
|
||||
2023-06-16 | Integrum | Integrum AB: Integrum appoints Jeffrey S. Zanni as President, U.S. | Pressreleaser | Visa Stäng |
|
||||
2023-06-12 | Redeye | Redeye: Integrum Q4 - An undeserved blow to the share | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-08 | Integrum | Integrum AB: Bokslutskommuniké maj 2022 - april 2023: FORTSATT BOLAGSUTVECKLING | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-06-08 | Integrum | Integrum AB: Year End Report May 2022 - April 2023: CONTINUING TO BUILD THE COMPANY | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-06-08 | Integrum | Integrum AB: Shirley Ryan AbilityLab receives a USD 8.7 million NIH grant to fund clinical trials including Integrum's e-OPRA Implant System | Pressreleaser | Visa Stäng |
|
||||
2023-06-01 | Integrum | Integrum AB: Integrum invites to Open House Event to celebrate its 25-year anniversary | Pressreleaser | Visa Stäng |
|
||||
2023-06-01 | Integrum | Integrum AB: Integrum and collaboration partners receive SEK 3.2 million in research grant for textile-based HOPE project | Pressreleaser | Visa Stäng |
|
||||
2023-05-29 | Integrum | Integrum AB: Integrum appoints Supply Chain Manager | Pressreleaser | Visa Stäng |
|
||||
2023-05-11 | Integrum | Integrum AB: Integrum announces the appointment of Scott Flora as adjunct board membe | Pressreleaser | Visa Stäng |
|
||||
2023-05-09 | Integrum | Integrum AB: Integrum's CEO Rickard Brånemark holds the keynote lecture at ISPO 2023 in Germany | Pressreleaser | Visa Stäng |
|
||||
2023-05-03 | Integrum | Integrum AB: Integrum moves into new head office at GoCo Health Innovation Cit | Pressreleaser | Visa Stäng |
|
||||
2023-05-02 | Integrum | Integrum AB: Integrum announces appointment of Jörgen Svanström as interim CFO | Pressreleaser | Visa Stäng |
|
||||
2023-04-28 | Integrum | Integrum AB: Integrum is granted patent approval for its OPRA™ Implant System in Australia | Pressreleaser | Visa Stäng |
|
||||
2023-03-13 | Redeye | Redeye: Integrum Q3 - On track, but still a challenging market outlook | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-02 | Integrum | Integrum AB: Integrum named to Fast Company's 2023 List of the World's Most Innovative Companies | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-02 | Integrum | Integrum AB: Integrum receives MDR certificate for the OPRA Implant System | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-01 | Integrum | Integrum AB: CORRECTION Interim report May - Jan 2022/23: SOLID GROWTH AND STRONGER MARKET PRESENCE | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-03-01 | Integrum | Integrum AB: RÄTTELSE Delårsrapport maj - jan 2022/23: Solid tillväxt och stärkt marknadsnärvaro | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-03-01 | Integrum | Integrum AB: Shirley Ryan AbilityLab receives US Department of Defense grant for clinical study of Integrum's e-OPRA Implant System | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-01 | Integrum | Integrum AB: Delårsrapport maj - jan 2022/23: Solid tillväxt och stärkt marknadsnärvaro | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-03-01 | Integrum | Integrum AB: Interim report May - Jan 2022/23: Solid growth and stronger market presence | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-01-26 | Integrum | Integrum AB: Integrum appoints Chief Operating Officer | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-01-20 | Integrum | Integrum AB: Integrum appoints Director of Quality Assurance and Regulatory Affairs | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-01-19 | Integrum | Integrum AB: Integrum's CFO will leave the company at the end of March 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-12-02 | Redeye | Redeye: Integrum Q2 - Preparing for the sprint | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-12-01 | Integrum | Integrum AB: NYU Langone Health initiates osseointegration program based on Integrum's OPRA[TM] Implant System | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-12-01 | Integrum | Integrum AB: Delårsrapport maj - okt 2022: Fortsatt stabil tillväxt visar att vi är på god väg att etablera OPRA[TM] i USA | Rapporter | Ladda ner | Visa Stäng |
|
||||
2022-12-01 | Integrum | Integrum AB: Interim report May - Oct 2022: Continued steady growth shows that we are on track to establish OPRA[TM] in the US | Rapporter | Ladda ner | Visa Stäng |
|
||||
2022-11-30 | Integrum | Integrum AB: Integrum provides an update on the clinical development programs of e-OPRA[TM] Implant System and Neuromotus[TM] | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-11-17 | Integrum | Integrum AB: Integrum presents health economic study of the OPRA[TM] Implant System showing long-term benefits for transfemoral amputees in the U.S. | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-11-02 | Integrum | Integrum AB: The University Hospital of Regensburg has performed its first surgery with Integrum's OPRA[TM] Implant System | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-10-27 | Integrum | Integrum AB: Integrum provides implant technology to newly established Center for Bionics at Massachusetts Institute of Technology | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-10-19 | Integrum | Integrum AB: Integrum har informerats om att Göteborgs universitet har lämnat över ärende gällande misstanke om avvikelse från god forskningssed till Npof | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-10-17 | Integrum | Integrum AB: Integrum receives ISO 13485 certification confirming its robust quality management system | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-10-11 | Integrum | Integrum AB: Integrum is granted patent approval for its OPRA[TM] Implant System from the US Patent and Trade Organization | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-09-28 | Integrum | Årsstämmokommuniké - Integrum AB | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-09-23 | Integrum | Integrum AB: Vetenskaplig artikel med fallbeskrivningar av Integrums implantat e-OPRA granskas av forskningsetisk kommitté på Chalmers tekniska högskola | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-09-13 | Integrum | Integrum AB: Oslo University Hospital diversifies its patient offering and scales up the use of Integrum's OPRA[TM] Implant System | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-09-08 | Integrum | Integrum AB: Integrum's CEO Rickard Brånemark presents at a leading conference of limb salvage in US | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-09-07 | Integrum | Integrum AB: Integrum publicerar årsredovisning 2021/22 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2022-09-01 | Redeye | Redeye: Integrum Q1 - Continuing on the positive trajectory | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-08-31 | Integrum | Integrum AB: Interim report May - Jul 2022: Steady sales growth fuelled by increased market penetration in the US | Rapporter | Ladda ner | Visa Stäng |
Rapporter |
Integrum AB: Interim report May – Jul 2022: Steady sales growth fuelled by increased market penetration in the USThe period May 1[st] 2022 – JUl 31[st] 2022
-4.8 MDR project and -12.8 Accounts Receivables, respectively.
Significant events in the period
Karolinska University Hospital treated its first patient.
He has held senior global marketing positions and brings over 25 years of experience in the marketing of orthopaedic implant systems.
CEO comment Integrum continues to deliver steady sales growth. During the past quarter, Integrums’ revenues amounted to SEK 17.2 million, representing a growth of 34 percent compared to the corresponding quarter last year. This marks a solid start for a new financial year and strengthens us in our endeavor for further growth. In our most important market – the US – we are proud to announce a growth of 45 percent. During the quarter, three new centers in the US performed their first surgeries. Also, the structure of the new treatment program within the US Department of Veterans Affairs (VA) is now in place, the first patients are being recruited and treated. For continued growth, we need to constantly expand our patient base. Most amputees suffering from a bad functioning socket prosthesis are still unaware that our OPRA[TM] Implant System may offer a considerably higher quality of life, much of our untapped potential lies in increased awareness among patients. We are in the US launching an extensive social media campaign and other PR activities to help increase awareness around the OPRA[TM] Implant System as a better alternative for transfemoral amputees. We also hosting an increasing number of OPRA[TM] Insight Forum where we gathered professionals and patients to educate them about the benefits of our treatment. Successful marketing is increasingly important in this phase of the company’s development. To streamline our market outreach, we have started to consolidate our marketing organization to our US subsidiary, which will oversee the company’s marketing efforts in the US and globally. To lead this updated organization we have recruited Ian Dawson, who has held senior global marketing positions in several leading medical device companies and brings over 25 years of experience in the marketing of orthopaedic implant systems. In his most recent role, he was leading the launch of the Zimmer Biomet orthopaedic robotic platform in the US, and we are very pleased to have managed to attract Ian to Integrum. This organizational update will help us in establishing the infrastructure needed to drive further growth. The list of top-performing and reputable medical institutions around the globe using our solution is growing. During the quarter, Karolinska University Hospital in Solna, Sweden, performed its first surgeries with Integrum OPRA[TM] Implant System and is now offering our innovative bone anchored prosthesis technology to patients. Integrum is not just growing in terms of sales, we are expanding our business and have decided to relocate to new premises. In the spring of 2023, Integrum will move headquarter to the GoCo House, in the center of Health Innovation City. This new life science district in Mölndal, Gothenburg, is set to cover over 200 000 square meters of newly developed offices and facilities, with the aim of promoting knowledge exchange, business collaboration, and world-class innovation in life science and health care. We are convinced that the move will not only bring us both more space for our ongoing expansion but also make us an even more attractive employer to those who want to join our journey to change amputee care forever. In close collaboration with health providers, leading surgeons, and rehabilitation professionals, and prosthetists, we are now even more forcefully continuing our efforts to improve access to our unique implant system with the aim of improving the quality of life for patients all over the world. This disclosure contains information that Integrum AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 31-08-2022 08:30 CET. |
||||
2022-08-29 | Integrum | Integrum AB: Integrum tidigarelägger delårsrapport för första kvartalet 2022/2023 från den 2 september till den 31 augusti | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-08-26 | Integrum | Kallelse till årsstämma i Integrum AB | Pressreleaser | Ladda ner | Visa Stäng |
|